Unknown

Dataset Information

Extracorporeal Membrane Oxygenation with Right Ventricular Assist Device for COVID-19 ARDS.


ABSTRACT:

Background

Right ventricular failure is an underrecognized consequence of COVID-19 pneumonia. Those with severe disease are treated with extracorporeal membrane oxygenation (ECMO) but with poor outcomes. Concomitant right ventricular assist device (RVAD) may be beneficial.

Methods

A retrospective analysis of intensive care unit patients admitted with COVID-19 ARDS (Acute Respiratory Distress Syndrome) was performed. Nonintubated patients, those with acute kidney injury, and age > 75 were excluded. Patients who underwent RVAD/ECMO support were compared with those managed via invasive mechanical ventilation (IMV) alone. The primary outcome was in-hospital mortality. Secondary outcomes included 30-d mortality, acute kidney injury, length of ICU stay, and duration of mechanical

SUBMITTER: Cain MT 

PROVIDER: S-EPMC7969863 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature